Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of gemcitabine hydrochloride
and alvocidib in treating patients with solid tumors. Drugs used in chemotherapy, such as
gemcitabine hydrochloride and alvocidib, use different ways to stop tumor cells from dividing
so they stop growing or die. Combining more than one drug may kill more tumor cells